These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5935729)

  • 61. [THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS].
    VITOLO A
    Bull Sci Med (Bologna); 1963; 135():396-402. PubMed ID: 14112984
    [No Abstract]   [Full Text] [Related]  

  • 62. [Our region's possibilities in the ambulatory treatment of pulmonary tuberculosis with the biweekly administration of a perfused triple combination of isoniazid, streptomycin and PAS].
    Burghard G; Petitjean R; Scherrer B; Schranz J
    Rev Tuberc Pneumol (Paris); 1970; 34(5):662-3. PubMed ID: 5496786
    [No Abstract]   [Full Text] [Related]  

  • 63. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 64. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 65. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas].
    Ursov IG; Volokitin FN; Borovinskaia TA
    Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002
    [No Abstract]   [Full Text] [Related]  

  • 66. Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
    Nitti V
    Chest; 1972 Jun; 61(6):589-98. PubMed ID: 4624281
    [No Abstract]   [Full Text] [Related]  

  • 67. [THERAPEUTIC RESULTS IN 180 ALCOHOLIC PATIENTS WITH PULMONARY TUBERCULOSIS].
    LEVENDEL L; VARADY T; BEDE L; KAROLYI A
    Tuberk Tudobetegsegek; 1963 Aug; 16():248-51. PubMed ID: 14085669
    [No Abstract]   [Full Text] [Related]  

  • 68. [Results of the treatment of children and adolescents in the early period of primary tuberculous infection].
    Mishina RG
    Probl Tuberk; 1968; 46(5):11-4. PubMed ID: 5304368
    [No Abstract]   [Full Text] [Related]  

  • 69. Corticosteroids in pulmonary tuberculosis. 3. Indications.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):62-73. PubMed ID: 5338901
    [No Abstract]   [Full Text] [Related]  

  • 70. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 71. [INFORMATION ON A NEW TECHNIQUE FOR ANTITUBERCULOSIS THERAPY].
    CASTELLARIERA J; GRANENAFUGUET P; COLLCOLOME F
    Folia Clin Int (Barc); 1964 Mar; 14():152-60. PubMed ID: 14156917
    [No Abstract]   [Full Text] [Related]  

  • 72. [The efficacy of treatment of diffuse infiltrative-pneumonic pulmonary tuberculosis].
    Pervova TN; Polevikt GK
    Probl Tuberk; 1966; 44(4):10-5. PubMed ID: 6011830
    [No Abstract]   [Full Text] [Related]  

  • 73. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 74. [Further considerations on antituberculosis chemotherapeutic action of p-aminosalicylic hydrazide: in vitro activity on Koch's bacillus resistant to streptomycin and isoniazid].
    CUGURRA F; BALDINI L
    Arch Ital Sci Farmacol; 1959 Oct; 9():529-31. PubMed ID: 13813224
    [No Abstract]   [Full Text] [Related]  

  • 75. Absorption of sulphonamides and antitubercular drugs from the rat lung.
    Burton JA; Schanker LS
    Xenobiotica; 1974 May; 4(5):291-6. PubMed ID: 4407063
    [No Abstract]   [Full Text] [Related]  

  • 76. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 77. [APROPOS OF 70 TUBERCULOUS MOSLEMS].
    ACCARD R; TOURAINE J
    J Med Bord; 1963 Sep; 140():1335-44. PubMed ID: 14090755
    [No Abstract]   [Full Text] [Related]  

  • 78. [Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation].
    Savula MM
    Probl Tuberk; 1973; 51(10):44-7. PubMed ID: 4784037
    [No Abstract]   [Full Text] [Related]  

  • 79. Corticosteroids in pulmonary tuberculosis. II. Importance of background factors.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):43-61. PubMed ID: 5338900
    [No Abstract]   [Full Text] [Related]  

  • 80. Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis.
    Phillips S
    Am Rev Respir Dis; 1967 Mar; 95(3):503-5. PubMed ID: 6066869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.